Oral squamous cell carcinoma (OSCC) ranks among the top 8 causes of cancer death worldwide, with only a 60% 5-year survival rate, highlighting the need for discovery of novel biomarkers and therapeutic targets. We have previously reported that expression of a panel of serine proteinase kallikreins (KLK 5, 7, 8, and 10) is correlated with formation of more aggressive OSCC tumors in a murine orthotopic OSCC model and is elevated in human OSCC. Current studies focus on understanding the potential role of KLK5 in OSCC progression. In initial studies, KLK levels in malignant OSCC cells (SCC25) were compared to cells from normal oral mucosa (OKF/6) and premalignant oral keratinocytes (pp126) using qPCR. A marked elevation of all KLKs was observed in aggressive SCC25 cells relative to OKF/6 cells. In normal skin, KLKs are involved in desquamation during epidermal differentiation via proteolytic cleavage of the desmosomal cadherin component desmoglein 1 (Dsg1). As loss of cell-cell cohesion is prevalent in tumor metastasis, Dsg1 integrity was evaluated. Results show that SCC25 cells exhibit cleavage of Dsg1 which is blocked by proteinase inhibitor treatment as well as by siRNA silencing of KLK5 expression. Furthermore, cell-cell aggregation assays demonstrate that silencing of KLK5 enforces cell-cell adhesion; conversely, overexpression of KLK5 in normal oral mucosal cells (OKF/6) enhances cell dispersal. These data suggest that KLK5 may promote metastatic dissemination of OSCC by promoting loss of junctional integrity through cleavage of desmoglein 1.
INTRODUCTION
Oral cavity cancer results in over 200,000 deaths annually and is one of the top eight most frequently diagnosed cancers worldwide (1) . The most common malignancy of the oral cavity is oral squamous cell carcinoma (OSCC), including tumors affecting the tongue, floor of the mouth, buccal mucosa, lips, palate and gingiva, causing more deaths than any other oral disease (2) (3) . According to National Cancer Institute statistics, about 23,110 new cases of oral cancer were diagnosed in 2009 in the United States (4) . Unfortunately, in spite of advancements in surgery, chemotherapy, and radiation, only 60% of these individuals will survive for five years. The high mortality associated with OSCC is due primarily to the detection of late-stage disease after the primary tumor has metastasized. Treatment of advanced OSCC is also associated with high morbidity and mortality, resulting from local, regional and distant metastasis (2) (3) . The cellular and biochemical factors that underlie locoregional and distant spread of the disease are poorly understood. Invasion and metastasis of OSCC require multiple cellular events including disruption of cell-cell adhesive contacts, cytoskeletal alterations, and basement membrane attachment, matrix protein proteolysis, and migration (5) (6) . Thus a more detailed analysis of the molecular events that contribute to OSCC metastasis are a necessary prerequisite for the development of novel early detection and treatment strategies that have a favorable impact on the survival of OSCC patients.
Human tissue kallikreins or kallikreinrelated peptidases (KLKs) constitute a single family of 15 highly conserved trypsin-or chymotrypsin-like serine proteases encoded by a large uninterrupted cluster of proteaseencoding genes (KLK1-15) co-localized on chromosome 19q13.4 (7) . In initial studies, we identified expression of a panel of kallikreins (KLK 5, 7, 8, and 10) that have a marked elevation in malignant OSCC relative to normal oral mucosa and normal tongue (8) . The physiologic roles and natural substrates for most KLKs have not been defined; however expression of multiple KLKs in a single tissue compartment suggests participation in proteolytic cascades (9) (10) (11) (12) . As KLK5 can auto-activate and contributes to activation of pro-KLK2, -3, -6, -7, -11, -12, and -14 zymogens, KLK5 may be considered an initiator of putative KLK proteolytic cascades (13) . In normal skin, KLK5 is involved in desquamation during epidermal differentiation via proteolytic cleavage of the desmosomal cadherin component desmoglein 1 (14) (15) .
Desmosomes are intercellular junctions that provide strong adhesion between cells. They are particularly abundant in tissues such as epithelia and cardiac muscle that are continually assailed by mechanical forces. Extracellularly, desmosomal adhesion is mediated by the desmosomal cadherins comprised of desmogleins (Dsg) and desmocollins (Dsc) (16) (17) (18) (19) . Previous studies have shown that loss of desmosomal adhesion can significantly disrupt tissue integrity (20) .
In the current study, the effect of modulating KLK5 levels on the expression and integrity of desmoglein 1 (Dsg1) was evaluated in normal oral keratinocytes and OSCC cells. Our data demonstrate that malignant OSCC cells exhibit cleavage of Dsg1 which can be blocked by treatment with proteinase inhibitors as well as by silencing of KLK5.
Modification of KLK5 expression also alters cell-cell aggregation and cohesion. These results suggest KLKs may contribute to metastatic dissemination of OSCC via a mechanism involving KLK5-catalyzed Dsg1 cleavage.
EXPERIMENTAL PROCEDURES

Antibodies-
Rabbit polyclonal antibodies to kallikrein 5, generated against a synthetic peptide based on the kallikrein loop area of kallikrein 5, were obtained from Abcam (Cambridge, MA). This antibody reacts with KLK5, but has no reactivity against KLKs 1-7 and 9-15. Mouse monoclonal anti-desmoglein 1 antibodies were purchased from BD Transduction Laboratories (San Jose, CA), and do not cross-react with Dsg2 or Dsg3 according to manufacturer's specifications. Mouse monoclonal anti-E-cadherin antibody was obtained from Invitrogen (Carlsbad, CA). Anti-GAPDH was purchased from Santa Cruz Biotechnology.
Immunohistochemical
AnalysisImmunohistochemical analysis was performed by analyzing tongue-derived specimens of microarrayed human OSCC and normal oral tissues (US Biomax).
Paraformaldehyde fixed, paraffin-embedded sections (4 μm) were de-paraffinized with xylene and rehydrated in a series of ethanol washes. Endogenous peroxidase activity was quenched with 3.3% hydrogen peroxide in methanol for 30 min. Antigen retrieval was enhanced by microwaving in 10mM sodium citrate pH 6.0. Nonspecific binding was blocked with 3% normal horse serum in PBS for 30 min. Sections were incubated for 1 hour at room temperature with primary antibody (1:15 -1:25 dilution) in 1% BSA in PBS. Staining was detected using an avidinbiotin horse radish peroxidase system (Vectastain Universal Elite ABC kit, Cat. # PK-6200, Vector Laboratories, Burlingame, CA, USA), with positive cells staining brown using diaminobenzidine chromogen and hydrogen peroxide substrate (Liquid DAB substrate pack #HK153-5K, BioGenex, San Ramon, CA). Analysis of tissue staining was done by light microscopy and scoring of KLK5 was assigned according to the average overall intensity of staining and was graded as follows: 0 = no staining, 1 = fine granular staining, 2 = somewhat coarse staining, 3 = very coarse staining. (23) . OKF/6 cells were maintained in keratinocyte-SFM (Gibco BRL, Gaithersburg, MD) supplemented with 100 U/ml penicillin, 100 ug/ml streptomycin, 0.2 ng/ml epidermal growth factor (EGF), 25 ug/ml bovine pituitary extract (BPE), and 0.4 mM CaCl 2 . pp126 cells were maintained in keratinocyte-SFM supplemented with 100 U/ml penicillin, 100 ug/ml streptomycin, 5 ng/ml EGF, and 50 ug/ml BPE (supplied with the medium). In some experiments, cells were cultured for up to 7 days in medium containing the proteinase inhibitors leupeptin (Sigma, 100 uM final concentration) and chymostatin (Sigma, 100 uM final concentration) (24) Nucleofector Kit (Amaxa GmbH, Germany). The resulting clonal cell lines were routinely maintained in the medium described above supplemented with G418 and were assessed for expression of KLK5 by qPCR and immunofluorescence microscopy (see below).
Quantitative Real Time PCR (qPCR)
Analysis-Total RNA was extracted with Trizol Reagent (Invitrogen) and reverse transcription was performed with 10 ug of the total RNA from each specimen using SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's protocol. The cDNA products were then diluted 1:10 and 5 ul of each were used for PCR templates. The following primer sequences were used at final concentrations of 167 nM for each: for KLK5 forward, 5'-GCA GGT AGA GAC TCC TGC CA -3' and reverse 5'-CAC AAG GGT AAT CTC CCC AG -3'; for KLK7 forward, 5'-ACC CTC AGT GCT GGA GAA GA -3' and reverse 5'-ACT GGG TCA AAG GTG GTG AA -3'; for KLK8 forward, 5'-AAG TGC ACC GTC TCA GGC -3' and reverse 5'-TCC TCA CAC TTC TTC TGG -3'; for KLK10 forward, 5'-CTC TGG CGA AGC TGC TG -3' and reverse 5'-ATA GGC TTC GGG GTC CA -3'; for Dsg1 forward, 5'-AGA TGC CTG ACT TGC GAG AT -3' and reverse 5'-CTA TCA TGC CGG AAG TTG GT -3'; for endogenous control gene phosphoglycerate kinase (PGK) forward, 5'-GGG CTG CAT CAC CAT CAT AGG -3' and reverse 5'-GAG AGC ATC CAC CCC AGG AGG -3'. DNA oligos were custom synthesized (Integrated DNA Technologies). Realtime PCR was performed with SYBR green Master Mix (Aplied Biosystems, Foster City, CA). PCR cycling conditions were 95°C for 13.5 min followed by 40 cycles of 95°C for 15 sec and 60°C for 30 sec. Melt curve cycling consisted of 81 30 sec cycles beginning at 55°C increasing by 0.5°C to 95°C. All reactions were carried out on an iCycleriQ real-time PCR detection system (Bio-Rad Laboratories). Each sample was analyzed in triplicate for each PCR measurement. Melting curves were checked to ensure specificity. Relative quantification of mRNA expression was calculated using the standard curve method with the endogenous housekeeping gene PGK level as normalizer and control sample as calibrator.
Western Blot Analysis-Cells were harvested by scraping in lysis buffer (modified RIPA Buffer, with an added protease inhibitor cocktail tablet) and samples were centrifuged at 6,000 rpm for 10 min at 4°C to produce supernatant. Protein concentration of samples was determined by using a detergent compatible protein assay kit (Bio-Rad). Proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE), and then transferred onto a polyvinylidene fluoride (PVDF) microporous membranes (Millipore). After blocking non-specific binding to membranes in 3% BSA in TBST for 1 hour at room temperature, membranes were incubated with primary antibodies for 3 hours at room temperature or overnight at 4°C, and then with HRPconjugated secondary antibodies. Immunoreactivity was determined by SuperSignal West Dura Extended Duration Substrate kit (Thermo Scientific). Blots were also probed with antibodies against GAPDH to ascertain equal protein loading. Images were acquired with Fuji Film LAS-4000 Luminescent Image Analyzer. Semiquantitative analysis of bands was performed by densitometry to evaluate the relative optical density of bands on a given gel. The relative optical densities are expressed on an arbitrary scale.
Immunofluorescence microscopyCells were placed on coverslips in 6 well dishes and were cultured to 80% confluence. Adherent cells were washed once with 37°C phosphate-buffered saline (PBS) once and fixed with 4% paraformaldehyde in PBS containing 0.12M Sucrose for 20 minutes. For intracellular antibodies, cells were permeabilized in 0.3% Triton X-100 in PBS for 5 minutes at room temperature. After blocking with 10% bovine serum albumin (BSA) in PBS for 1 hour, the cells were labeled with primary antibodies for 1 hour, followed by the respective Alexa-Fluor-labeled secondary antibodies for 30 minutes. Coverslips were removed from 6 well plates, air dried, and mounted to slide with Gelvatol + DABCO (sigma d2522) with the cell side face down. Specimens were examined and images were acquired with an Olympus IX81 Inverted Spinning Disk Confocal Microscope system using the widefield fluorescence function.
Transmission Electron MicroscopySamples were fixed using 2 % glutaraldehyde and 2% paraformaldehyde in 0.1M cacodylate buffer, washed with 0.1M cacodylate buffer; then with 1% OsO 4 , 0.8% potassium ferricyanide in 0.1M cacodylate buffer for 30 minutes at room temperature for secondary fixation. After rinsing with ultra pure water, 2% aqueous uranyl acetate was used for 30 minutes for tertiary fixation. After washing, samples were dehydrated in ascending concentrations of EtOH followed by dehydrating with 100% acetone, then infiltrated with Epon/Spurr's Resin. The samples were embedded and polymerized overnight. Coverslips were removed using liquid nitrogen and samples were returned to the oven to complete polymerization (overnight). Ultrathin sections were cut with Reichert Ultracut R ultramicrotome and collected on celloidine-coated 100-mesh nickel grids. Thin sections were examined with a JEOL 1400 transmission electron microscope (Jeol, Tokyo, Japan).
Cell
Aggregation AssaySemiquantitative analysis of cell-cell aggregation was performed by monitoring aggregation of single-cell suspensions as previously described (25) . Cells were grown in 100-mm dishes and removed from the substrate with 0.5% EDTA in PBS. The cells were then counted, rinsed in PBS+ containing 0.5% BSA, and incubated in single-cell suspension ( 
Dispase-based Dissociation Assay-
Relative dissociation of cell-cell adherent monolayers was evaluated using a dispase-based dissociation assay as previously described (26) . Paired cell lines for analysis (SCC25 and SCC25-KLK5-KD cells; or OKF/6 and OKF/6-KLK5+) were cultured in triplicate in 60-mm dishes to 80% confluence, washed twice with PBS and then incubated in 2ml of dispase for 30 min to release cells as a monolayer. Following careful washing with PBS, cell sheets were transferred to 15 ml conical tubes in a final volume of 5ml PBS and were subjected to 50 inversion cycles using a rocking platform. The resulting cellular fragments were placed in tissue culture plates and the number of fragments (irrespective of fragment size) was enumerated. Statistical analysis (twotailed Student's t-test) was performed on the mean number of fragments from triplicate cultures and the results shown are representative of at least three independent experiments. (8, 27 Fig. 2, lanes 1,3,5] . Cells cultured for 7 days with chymostatin and leupeptin, inhibitors that block KLK5 and KLK7 activities (36) (37) (38) , exhibited only the 165 kDa Dsg1 protein [ Fig. 2,  lanes 2,4,6] , suggesting that the 130 kDa specie represents a proteolytic Dsg1 degradation product.
RESULTS
Expression of kallikreins in normal and
malignant oral cells -Microarray-based profiling of aggressive OSCC identified a panel of serine proteinase KLKs (KLK 5, 7, 8, and 10) that are highly expressed in poorly-differentiated murine OSCC tumors and are abundant in human OSCC
Silencing of KLK5 modulates Dsg1
cleavage and desmosome formation-To evaluate the effect of altered KLK5 expression on Dsg1 cleavage, KLK5 expression was silenced in SCC25 cells using shRNA (designated SCC25-KLK5-KD). Downregulation of KLK5 was confirmed using immunofluorescence microscopy and qPCR, showing a 60-85% knockdown of expression [ Fig 3A-C] . Examination of Dsg1 integrity by western blotting shows a significant loss of the Dsg1 cleavage fragment in SCC25-KLK5-KD cells [ Fig.  3D, lanes 3,4; Fig. 3E ] relative to parental SCC25 cells [ Fig. 3D, lanes  1,2] . Controls show that the classic cadherin E-cadherin is not differentially processed in response to KLK-5 modification [ Fig. 3D, middle panel;  Fig. 3F ]. GAPDH blots demonstrate equal protein loading [ Fig 3D, lower  panel; Fig. 3F ].
To evaluate whether cleavage of Dsg1 results in altered ultrastructural integrity, transmission electron microscopy (TEM) was used to examine cell-cell junctions and the number of desmosomes/field in parental SCC25 vs SCC25-KLK5-KD cell images was enumerated. While electron dense desmosomal cadherin plaques are relatively rare in the cell-cell junctions of SCC25 cells (not shown), SCC25-KLK5-KD cells form abundant desmosomal contacts [ Fig. 4A]. Quantitative analysis shows SCC25 cells form 0.65 desmosome clusters per field, whereas SCC25-KLK5-KD cells form 2.06 demosome clusters per field, indicating that reducing KLK5 expression results in a 3-fold increase in desmosome number [ Fig. 4B] .
Overexpression of KLK5 induces Dsg1 cleavage in normal oral mucosal cells-
To evaluate whether induced expression of KLK5 can initiate Dsg1 cleavage, KLK5 expression was increased in OKF/6 normal oral mucosal cells (designated OKF/6-KLK5+). Upregulation of KLK5 was confirmed using immunofluorescence microscopy and qPCR [ Fig. 5A-C] . Examination of Dsg1 integrity by western blotting demonstrates the appearance of the 130 kDa Dsg1 cleavage product in KLK5-transfected OKF/6 cells [Fig. 5D, lane 3;  Fig. 5E ] whereas only intact 165 kDa Dsg1 is observed in parental and vectortransfected cells [Fig. 5D, lanes 1-2; Fig.  5E ].
Controls show that the classic cadherin E-cadherin is not differentially processed in response to KLK-5 modification [ Fig. 5D, middle panel;  Fig. 5F ]. GAPDH blots demonstrate equal protein loading [ Fig. 5D, lower  panel; Fig. 5F ]. Fig. 6A , E] and were present as small aggregates and single cells at 7h of incubation [ Fig.  6F] . In contrast, KLK5 knockdown resulted in significant differences in aggregation kinetics detectable as early as 3 h [Fig. 6B,E (p<.05) , G], with highly significant differences observed at longer time points (p<0.001). At 7h, large multicellular aggregates were present with no visible single cells. Conversely, normal oral keratinocytes rapidly form robust aggregates [ Fig. 6C,  H, I ]. However, introduction of KLK5 expression significantly delays aggregation kinetics as early as 3h (p<.05), with highly significant differences observed at longer time points (p<.001).
Modulation of KLK5 expression alters cell-cell aggregation kinetics and monolayer dissociation-
Similar to results observed in parental SCC25 cells, the majority of the OKF/6-KLK5+ population remains as single cells at 7h [Fig. 6J] .
To examine the relative resistance of epithelial cell sheets to dissociation into single cells, a dispase-based dissociation assay was used. Harvested cell monolayers were pulsed with dispase and subjected to controlled mechanical agitation followed by semi-quantitative analysis of sheet fragmentation (26, 39) . SCC25 monolayers dissociated into numerous smaller fragments consistent with reduced epithelial cohesion [ Fig.  7A,C] . In contrast, SCC25-KLK-KD cells retained better epithelial integrity, as evidenced by a 14-fold reduction in fragment number [ Fig.  7B,C] .
Conversely, OKF/6 cells remained largely clustered following dispase treatment [ Fig. 7D,F] . However, introduction of KLK5 expression resulted in a relative 6-fold loss of cohesivity of OKF/6-KLK5+ aggregates [ Fig. 7 E,F] .
DISCUSSION
Human tissue KLKs are aberrantly expressed in multiple malignancies including those of the prostate, breast, and ovary (9-12). While accumulating data support the clinical utility of various KLKs as prognostic biomarkers in these cancers, KLK expression has not been extensively evaluated in OSCC. Using cDNA microarray screening of aggressive OSCC cells, combined with qPCR and immunohistochemical methods, we previously reported that KLK-5, -7, -8, and -10 are abundantly expressed in OSCC (8, 27) . Further, a recent study correlates upregulated KLK-4 and -7 expression with poor survival in OSCC patients (40) . Although the potential functions of these KLKs are not fully elucidated, emerging data suggest that analysis of KLK expresion may provide a useful clinical parameter for molecular classification of oral SCC lesions. Concurrent with upregulation of KLKs in OSCC, aberrant staining of desmosomal components including desmogleins and desmocollins is also observed in human OSCC relative to normal oral mucosa (30, 31, 40) . Data in the current study support these findings, showing both reduced staining intensity and loss of junctional localization for Dsg1 in a panel of human tongue tumors.
To test the hypothesis that KLK-5 may contribute to OSCC progression via modulation of cell-cell junctional integrity, in the current study the effect of KLK5 expression on Dsg1 processing was evaluated. Our results show that acquisition of KLK5 expression results in cleavage of Dsg-1, while processing of functionally related cell adhesion molecules including desmocollin-1, desmoglein-3 and E-cadherin was not observed.
Dsg-1 proteolysis was associated with a corresponding loss of cell-cell adhesive function as assessed by transmission electron microscopy together with functional assays of cellcell aggregation and dispersal. Indeed, downregulation of KLK5 expression in malignant SCC25 cells significantly enforced cell-cell adhesion, as demonstrated by both cell-cell aggregation and dissociation assays. In contrast, overexpression of KLK5 in normal oral mucosal OKF/6 cells led to reduced cell-cell cohesion.
Cell-cell adhesion is an essential function that contributes to the maintenance of tissue integrity and barrier function (41, 42) . Within the normal epidermis, desmosomes are present at extensive keratinocyte cellcell contacts and provide strong intercellular adhesion. Desquamation, the process of shedding of superficial corneocytes, has been shown to involve KLK-mediated proteolytic processing of corneodesmosin, Dsg1, and desmocollin 1 (9, 14, 15) . Direct cleavage of recombinant Dsg1 by KLK5 and identification of KLK5 cleavage sites in the Dsg1 extracellular domain have also been reported (32) . KLK5-catalyzed Dsg1 cleavage occurs within the first three extracellular cadherin repeat domains (ECI -ECIII), which mediate heterophilic binding to desmocollins (32) , suggesting that KLK5 action may destabilize Dsg1 structure and abolish adhesion to desmocollins on neighboring cells. Moreover, extracellular Dsg1 proteolytic fragments generated by KLK5 may further perturb intercellular adhesion by competing with intact Dsg1 and desmocollin 1 molecules for binding.
Desquamation is further regulated by the protease inhibitor lympho-epithelial Kazal-type related inhibitor (LEKTI) encoded by SPINK5 (serine protease inhibitor Kazal-type 5) (43) . Loss of LEKTI expression and/or function leads to dysregulated proteolysis in the outer epidermal layers, loss of cell-cell cohesion, and defective barrier function (15) .
Interestingly, transcriptomic profiling has shown that expression of the SPINK5 gene is significantly downregulated in human tongue tumors relative to normal tongue (44) .
Together with our report of upregulated KLK5 expression in human tongue tumors (8) and the current results showing KLK5-mediated Dsg1 cleavage, these data suggest that KLK5 may potentiate metastatic dissemination of OSCC by contributing to dissolution of Dsg1-containing cell-cell contacts, thereby modifying epithelial cohesion.
Although our data implicate KLK5 activity in Dsg1 processing, the potential involvement of a downstream proteinase(s) that is activated by KLK5 cannot be ruled out using the current approach. Pro-KLK5 has been shown to undergo auto-activation and may process downstream zymogens including pro-KLK7 or other pro-KLKs (13,45) that could functionally contribute to Dsg1 cleavage. Furthermore, it was recently demonstrated that the transmembrane serine proteinase matriptase, the zymogen of which undergoes highly efficient autolysis, functions to activate pro-KLKs in vitro and in vivo (46) . As these data suggest the potential presence of a regulatory node further upstream in the zymogen activation cascade, future analysis of matriptase expression in OSCC is warranted. 4,6 ) of leupeptin (100 uM) and chymostatin (100 uM) for 1, 2, or 7 days prior to lysis and electrophoresis on 9% SDS-polyacrylamide gels. Proteins were transferred to PVDF membrane and immunoblotted with anti-Dsg1 (1:1000) followed by peroxidase-conjugated secondary antibody (1:4000) and SuperSignal West Dura Extended Duration substrate. Arrows denote migration position of full length Dsg1 (165 kDa); arrowheads denote migration position of cleavage product (~130 kDa). 
